Niki BioSolutions, Inc. (NIKI) Net income 2018–2025
Niki BioSolutions, Inc. (NIKI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.4MFY2025 · since FY2018: -$14.8M → -$1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.4M | +68.1% |
| FY2024 | -$4.3M | -51.1% |
| FY2023 | -$2.8M | +71.2% |
| FY2022 | -$9.8M | +60.9% |
| FY2021 | -$25.0M | -609.1% |
| FY2020 | $4.9M | +124.5% |
| FY2019 | -$20.1M | -35.6% |
| FY2018 | -$14.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net marginNIKI Gross profitNIKI Gross marginNIKI Operating incomeNIKI Operating marginNIKI Operating cash flowNIKI Free cash flowNIKI Capital expendituresNIKI Return on equityNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Total liabilitiesNIKI Shareholders’ equityNIKI overview →